Strata Biosciences is a privately funded functional genomics company pioneering the implementation of proprietary high-throughput gene knockout technologies for gene discovery, drug target identification and validation. Combining molecular biology, high-throughput screening, bioinformatics and cell-based models, Strata Biosciences has the capacity of validating 100 genes per month as potential drug targets. The company has research programs in the areas of prostate, breast and ovarian cancer and immune regulation
